Sale

Market Size

South Korea General Anesthesia Market Share, Size, Forecast: By Drug Type: Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Others; By Route of Administration: Intravenous, Inhalation; By Surgery Type: Heart Surgery, Cancer Surgery, Knee and Hip Replacements, Others; By End-use; Competitive Landscape; 2024-2032

South Korea General Anesthesia Market Size

The South Korea general anesthesia industry is expected to grow at a CAGR of 4.5% between 2024 and 2032. Factors such as the increase in surgeries and diagnostic procedures due to the growing elderly population and the development of chronic diseases are primarily bolstering the market growth. As the older population grows, more procedures are being performed, which raises the need for general anaesthesia in South Korea.

 

South Korea General Anesthesia Market Report Snapshots

South Korea General Anesthesia Market Size

South Korea General Anesthesia Market Analysis

South Korea General Anesthesia Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers    
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
7    Opportunities and Challenges in the Market
8    South Korea General Anesthesia Market Overview

    8.1    Key Industry Highlights
    8.2    South Korea General Anesthesia Historical Market (2018-2023) 
    8.3    South Korea General Anesthesia Market Forecast (2024-2032)
9    South Korea General Anesthesia Market by Drug Type
    9.1    Propofol
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2023)
        9.1.3    Forecast Trend (2024-2032)
    9.2    Sevoflurane
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2023)
        9.2.3    Forecast Trend (2024-2032)
    9.3    Desflurane
        9.3.1    Market Share
        9.3.2    Historical Trend (2018-2023)
        9.3.3    Forecast Trend (2024-2032)
    9.4    Dexmedetomidine
        9.4.1    Market Share
        9.4.2    Historical Trend (2018-2023)
        9.4.3    Forecast Trend (2024-2032)
    9.5    Others
10    South Korea General Anesthesia Market by Route of Administration
    10.1    Intravenous
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2023)
        10.1.3    Forecast Trend (2024-2032)
    10.2    Inhalation
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2023)
        10.2.3    Forecast Trend (2024-2032)
11    South Korea General Anesthesia Market by Surgery Type
    11.1    Heart Surgery
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2023)
        11.1.3    Forecast Trend (2024-2032)
    11.2    Cancer Surgery
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2023)
        11.2.3    Forecast Trend (2024-2032)
    11.3    Knee and Hip Replacements
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2023)
        11.3.3    Forecast Trend (2024-2032)
    11.4    General Surgery
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2023)
        11.4.3    Forecast Trend (2024-2032)
    11.5    Others
12    South Korea General Anesthesia Market by End-use 
    12.1    Hospitals
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2023)
        12.1.3    Forecast Trend (2024-2032)
    12.2    Ambulatory Surgical Centres
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2023)
        12.2.3    Forecast Trend (2024-2032)
13    Market Dynamics
    13.1    SWOT Analysis
        13.1.1    Strengths
        13.1.2    Weaknesses
        13.1.3    Opportunities
        13.1.4    Threats
    13.2    Porter’s Five Forces Analysis
        13.2.1    Supplier’s Power
        13.2.2    Buyer’s Power
        13.2.3    Threat of New Entrants
        13.2.4    Degree of Rivalry
        13.2.5    Threat of Substitutes
    13.3    Key Indicators for Demand
    13.4    Key Indicators for Price 
14    Competitive Landscape
    14.1    Market Structure
    14.2    Company Profiles
        14.2.1    Fresenius Kabi Korea Ltd
            14.2.1.1    Company Overview
            14.2.1.2    Product Portfolio
            14.2.1.3    Demographic Reach and Achievements
            14.2.1.4    Certifications
        14.2.2    Hana Pharm Co., Ltd.
            14.2.2.1    Company Overview
            14.2.2.2    Product Portfolio
            14.2.2.3    Demographic Reach and Achievements
            14.2.2.4    Certifications
        14.2.3    Daewon Pharmaceutical Co., Ltd
            14.2.3.1    Company Overview
            14.2.3.2    Product Portfolio
            14.2.3.3    Demographic Reach and Achievements
            14.2.3.4    Certifications
        14.2.4    Pfizer Ltd.
            14.2.4.1    Company Overview
            14.2.4.2    Product Portfolio
            14.2.4.3    Demographic Reach and Achievements
            14.2.4.4    Certifications
        14.2.5    Baxter International Inc. 
            14.2.5.1    Company Overview
            14.2.5.2    Product Portfolio
            14.2.5.3    Demographic Reach and Achievements
            14.2.5.4    Certifications
        14.2.6    AbbVie Inc.
            14.2.6.1    Company Overview
            14.2.6.2    Product Portfolio
            14.2.6.3    Demographic Reach and Achievements
            14.2.6.4    Certifications
        14.2.7    Others  
15    Key Trends and Developments in the Market 

 

List of Key Figures and Tables

1.    South Korea General Anesthesia Market: Key Industry Highlights, 2018 and 2032
2.    South Korea General Anesthesia Historical Market: Breakup by Drug Type, 2018-2023
3.    South Korea General Anesthesia Market Forecast: Breakup by Drug Type, 2024-2032
4.    South Korea General Anesthesia Historical Market: Breakup by Route of Administration, 2018-2023
5.    South Korea General Anesthesia Market Forecast: Breakup by Route of Administration, 2024-2032
6.    South Korea General Anesthesia Historical Market: Breakup by Surgery Type, 2018-2023
7.    South Korea General Anesthesia Market Forecast: Breakup by Surgery Type, 2024-2032
8.    South Korea General Anesthesia Historical Market: Breakup by End-use, 2018-2023
9.    South Korea General Anesthesia Market Forecast: Breakup by End-use, 2024-2032
10.    South Korea General Anesthesia Market Structure

Key Questions Answered in the Report

The South Korea general anesthesia market is projected to grow at a CAGR of 4.5% between 2024 and 2032.

Continuous research and development, an increased geriatric population, the development of the pharmaceutical sector, and growth opportunities for biostartups are the major drivers of the South Korea general anesthesia industry.

Research and development activities in the pharmaceutical sector and technological advances in the medical field are the key trends of the market.

The dominant type of general anesthesia in the South Korea general anesthesia industry are propofol, sevoflurane, desflurane, and dexmedetomidine, among others.

The major players in the industry are Fresenius Kabi Korea Ltd., Hana Pharm Co., Ltd., Daewon Pharmaceutical Co., Ltd., Pfizer Ltd., Baxter International Inc., and AbbVie Inc., among others.

Purchase Full Report

Datasheet

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER